Provinces must act to prevent another OxyContin debacle

 By Vanessa Gruben and Louise Bélanger-Hardy This past week, 10 provincial governments have accepted a class-action settlement with Purdue Pharma, the maker of OxyContin.  The settlement concerns the misleading claims Purdue Pharma allegedly made to physicians about the addictive nature of the drug. These claims may have contributed to Canada’s